Capsugel CEO Driesen Plots Post-Pfizer Course
This article was originally published in The Tan Sheet
Executive Summary
Guido Driesen, president and CEO of Capsugel, says the oral dosage technology firm is having a record year after being divested by Pfizer. In an interview, he discusses the firm’s applications for OTC drugs and nutritionals, as well as Capsugel’s international expansion.